Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Davita Inc (DVA) vs Verizon Communications Inc (VZ) Price & Performance

Davita IncTrade
Verizon Communications IncTrade

Price performance (Past 24H)

Key statistics

Davita Inc vs Verizon Communications Inc — how do they compare? Davita Inc trades at $175.04 (market cap $11.28B), while Verizon Communications Inc trades at $43.82 (market cap $190.16B). The key difference: Verizon Communications Inc is far larger — about 16.9× Davita Inc's market cap, and Verizon Communications Inc pays a 6.18% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Verizon Communications Inc for 109 Days on average.

DVAVZ
Market Cap
$11.28B$190.16B
Volume
650,29415,790,993
Sector
HealthMedia
52-Week High
$240.96$51.45
52-Week Low
$103.87$38.40
Typical Hold Time
113 Days109 Days
Enterprise Value
$24.00B$376.87B
Dividend Yield
—6.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Davita Inc

DaVita (DVA) trades at $177.02, down 1.87% on the day, showing mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company demonstrates strong earnings beats with Q2 2026 EPS of $4.02 exceeding expectations of $3.88, while revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026. Recent developments include expanding value-based care partnerships with Humana, potentially benefiting over 10,000 Medicare Advantage members.

The outlook remains cautiously optimistic with 43% analyst buy ratings and a $235.67 consensus price target suggesting 33% upside. However, rising debt-to-asset ratios (65.55% in 2025) and margin pressures from Q2 2026 create headwinds. Key risks include regulatory changes in healthcare reimbursement and competitive pressures in dialysis services.

Verizon Communications Inc

Verizon (VZ) trades at $46.35, up 0.8% with a bearish technical signal despite recent earnings beats. The stock shows attractive valuation metrics with P/E of 11.9 and dividend yield support, while fundamentals indicate stable revenue growth and strong cash flow generation. Recent corporate developments include board appointments and a joint venture with telecom peers to expand coverage.

Outlook remains balanced with value appeal from dividends and cash flow offset by competitive pressures and debt levels. Key catalysts include Q3 earnings on October 26, 2026, while risks involve industry competition and capital expenditure requirements. Analyst consensus leans hold with $48.58 price target suggesting modest upside potential.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DVA
91% Buy9% Sell
Avg holding period · 113 Days
VZ
86% Buy14% Sell
Avg holding period · 109 Days

Top news

Latest headlines on both assets

About Davita Inc

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Read more on DVA →

About Verizon Communications Inc

Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.

Read more on VZ →